The Medical Genome Reference Bank, which currently holds data for more than 2,500 healthy elderly Australians, could help scientists understand the genetics of healthy aging.
The Scottish bioinformatics firm will crunch multi-omic datasets to assist Charles River Laboratories in "data-driven" drug discovery.
The Michael J. Fox Foundation-led project aims to lead researchers to new insights about biomarkers indicating Parkinson's disease progression.
While the Oxford, UK-based company has focused on drug development partnerships to date, it is also keen to see uptake of genetic disease risk screening by the NHS.
The companies will combine clinical genetic testing services with data management technology to support precision medicine for rare diseases.
The Chan Zuckerberg Initiative is leading efforts to build cloud infrastructure, scale the platform, and distribute data from the project.
The partners will integrate medical information into LunaDNA pulled from electronic health records via Medfusion's application program interfaces.
The center, launched by the National University of Ireland Galway, plans to train 115 doctoral students in genomics data science over the next seven years.
The companies will build clinical-genomic datasets to serve medical practitioners at the point of care as well as inform drug development.
At the NCI's Childhood Cancer Data Initiative Symposium, speakers emphasized measures such as data harmonization and the need for longitudinal data collection.
Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing.
Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.
Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports.
In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.